about
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.Precision medicine for acute myeloid leukemiaCytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia.MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Personalized therapy for acute myeloid leukemia.
@en
Personalized therapy for acute myeloid leukemia.
@nl
type
label
Personalized therapy for acute myeloid leukemia.
@en
Personalized therapy for acute myeloid leukemia.
@nl
prefLabel
Personalized therapy for acute myeloid leukemia.
@en
Personalized therapy for acute myeloid leukemia.
@nl
P2860
P1433
P1476
Personalized therapy for acute myeloid leukemia
@en
P2093
Judith E Karp
P2860
P304
P356
10.1158/2159-8290.CD-13-0832
P577
2013-12-01T00:00:00Z